WAKAMOTO PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 4512 for the last quarter is 1.97 B JPY, and it's 11.94% higher compared to the previous quarter. The net income of Q3 23 is 17.26 M JPY.